Literature DB >> 26307494

Early onset Charcot-Marie-Tooth neuropathy type 2A and severe developmental delay: expanding the clinical phenotype of MFN2-related neuropathy.

Maria Tufano1, Gerarda Cappuccio2, Gaetano Terrone2, Fiore Manganelli3, Chiara Pisciotta3, Alessandro Geroldi4, Simona Capponi4, Ennio Del Giudice2.   

Abstract

Charcot-Marie-Tooth (CMT) syndromes are a group of clinically heterogeneous disorders of the peripheral nervous system. Mutations of mitofusin 2 (MFN2) have been recognized to be associated with CMT type 2A (CMT2A). CMT2A is primarily an axonal disorder resulting in motor and sensory neuropathy. We report a male child with psychomotor delay, dysmorphic features, and weakness of lower limbs associated with electrophysiological features of severe, sensory-motor, axonal neuropathy. The patient was diagnosed with early onset CMT2A and severe psychomotor retardation associated with c.310C>T mutation (p.R104W) in MFN2 gene. CMT2A should be considered in patients with both axonal sensory-motor neuropathy and developmental delay.
© 2015 Peripheral Nerve Society.

Entities:  

Keywords:  Charcot-Marie-Tooth neuropathy type 2A; MFN2; electrophysiological study; global developmental delay

Mesh:

Substances:

Year:  2015        PMID: 26307494     DOI: 10.1111/jns.12148

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  7 in total

1.  Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model.

Authors:  Yueqin Zhou; Sharon Carmona; A K M G Muhammad; Shaughn Bell; Jesse Landeros; Michael Vazquez; Ritchie Ho; Antonietta Franco; Bin Lu; Gerald W Dorn; Shaomei Wang; Cathleen M Lutz; Robert H Baloh
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

2.  Exome sequencing reveals a novel MFN2 missense mutation in a Chinese family with Charcot-Marie-Tooth type 2A.

Authors:  Yi You; Xiaodong Wang; Shan Li; Xiuli Zhao; Xue Zhang
Journal:  Exp Ther Med       Date:  2018-07-24       Impact factor: 2.447

3.  Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study.

Authors:  Menelaos Pipis; Shawna M E Feely; James M Polke; Mariola Skorupinska; Laura Perez; Rosemary R Shy; Matilde Laura; Jasper M Morrow; Isabella Moroni; Chiara Pisciotta; Franco Taroni; Dragan Vujovic; Thomas E Lloyd; Gyula Acsadi; Sabrina W Yum; Richard A Lewis; Richard S Finkel; David N Herrmann; John W Day; Jun Li; Mario Saporta; Reza Sadjadi; David Walk; Joshua Burns; Francesco Muntoni; Sindhu Ramchandren; Rita Horvath; Nicholas E Johnson; Stephan Züchner; Davide Pareyson; Steven S Scherer; Alexander M Rossor; Michael E Shy; Mary M Reilly
Journal:  Brain       Date:  2020-12-01       Impact factor: 13.501

Review 4.  Genetic Neuropathy Due to Impairments in Mitochondrial Dynamics.

Authors:  Govinda Sharma; Gerald Pfeffer; Timothy E Shutt
Journal:  Biology (Basel)       Date:  2021-03-26

5.  Aberrant Mitochondrial Dynamics and Exacerbated Response to Neuroinflammation in a Novel Mouse Model of CMT2A.

Authors:  Filippos Stavropoulos; Irene Sargiannidou; Louiza Potamiti; Alexia Kagiava; Mihalis I Panayiotidis; Ji Hyun Bae; Su Cheong Yeom; Jae Young Lee; Kleopas A Kleopa
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

6.  Clinical and genetic features of a cohort of patients with MFN2-related neuropathy.

Authors:  Elena Abati; Arianna Manini; Daniele Velardo; Roberto Del Bo; Laura Napoli; Federica Rizzo; Maurizio Moggio; Nereo Bresolin; Emilia Bellone; Maria Teresa Bassi; Maria Grazia D'Angelo; Giacomo Pietro Comi; Stefania Corti
Journal:  Sci Rep       Date:  2022-04-13       Impact factor: 4.379

7.  Molecular modelling of mitofusin 2 for a prediction for Charcot-Marie-Tooth 2A clinical severity.

Authors:  Małgorzata Beręsewicz; Łukasz Charzewski; Krystiana A Krzyśko; Andrzej Kochański; Barbara Zabłocka
Journal:  Sci Rep       Date:  2018-11-15       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.